Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Jon C. Ogg | May 19, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont…

Chris Lange | May 12, 2020 at 9:36 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The April 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | May 8, 2020 at 11:32 AM EDT

Gilead Sciences Gains Remdesivir Approval in Japan

Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved…

Jon C. Ogg | Apr 27, 2020 at 9:08 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, American Air, Amex, Beyond Meat, Caterpillar, Clorox, eBay, Gilead, Twitter, Verizon, Wayfair and More

Monday's top analyst upgrades and downgrades included Amazon.com, American Airlines, American Express, Beyond Meat, Caterpillar, Clorox, eBay, Gilead Sciences, Twitter,…

Chris Lange | Apr 27, 2020 at 8:47 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 20, 2020 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago…

Jon C. Ogg | Apr 16, 2020 at 7:17 PM EDT

Stock Futures Surge as Gilead’s Remdesivir Could Be COVID-19 Top Treatment Candidate

While the COVID-19 pandemic wrecked the stock market and the economy, the recent rally in the stock market has been…

Lee Jackson | Apr 14, 2020 at 8:03 AM EDT

RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential

These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with…

Chris Lange | Apr 13, 2020 at 9:40 AM EDT

Big Biotechs Scare Off Short Sellers

The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Jon C. Ogg | Apr 7, 2020 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: BHP, Disney, EA, Gilead, Immunomedics, KeyCorp, Peloton, Shopify, Sunnova, Take-Two and More

Tuesday's top analyst upgrades and downgrades included BHP, Electronic Arts, Gilead Sciences, Immunomedics, KeyCorp, Peloton Interactive, Shopify, Sunnova Energy, Take-Two…

Lee Jackson | Apr 2, 2020 at 7:07 AM EDT

5 Blue Chip Stocks to Buy Now With Huge Piles of Cash and Very Low Debt

These five top companies have large troves of cash and very little debt. Their stocks make sense for long-term growth…

Paul Ausick | Mar 31, 2020 at 1:17 PM EDT

Court Rejects Patent Protection, Crushing Amarin Stock

Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news,…

Chris Lange | Mar 30, 2020 at 10:54 AM EDT

Big Pharma Advances on COVID-19

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Paul Ausick | Mar 30, 2020 at 10:41 AM EDT

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health…

Chris Lange | Mar 25, 2020 at 9:45 AM EDT

Major Biotechs Get Mixed Message on Short Interest

The March 13 short interest data has been compared with the previous report, and short interest moves in these selected…

1 … 7 8 9 10 11 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

Short Sellers Raise the Stakes in Major Biotechs

Gilead Sciences Gains Remdesivir Approval in Japan

Top Analyst Upgrades and Downgrades: Amazon, American Air, Amex, Beyond Meat, Caterpillar, Clorox, eBay, Gilead, Twitter, Verizon, Wayfair and More

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Stock Futures Surge as Gilead’s Remdesivir Could Be COVID-19 Top Treatment Candidate

RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential

Big Biotechs Scare Off Short Sellers

Tuesday’s Top Analyst Upgrades and Downgrades: BHP, Disney, EA, Gilead, Immunomedics, KeyCorp, Peloton, Shopify, Sunnova, Take-Two and More

5 Blue Chip Stocks to Buy Now With Huge Piles of Cash and Very Low Debt

Court Rejects Patent Protection, Crushing Amarin Stock

Big Pharma Advances on COVID-19

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

Major Biotechs Get Mixed Message on Short Interest

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

Short Sellers Raise the Stakes in Major Biotechs

Gilead Sciences Gains Remdesivir Approval in Japan

Top Analyst Upgrades and Downgrades: Amazon, American Air, Amex, Beyond Meat, Caterpillar, Clorox, eBay, Gilead, Twitter, Verizon, Wayfair and More

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Stock Futures Surge as Gilead’s Remdesivir Could Be COVID-19 Top Treatment Candidate

RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential

Big Biotechs Scare Off Short Sellers

Tuesday’s Top Analyst Upgrades and Downgrades: BHP, Disney, EA, Gilead, Immunomedics, KeyCorp, Peloton, Shopify, Sunnova, Take-Two and More

5 Blue Chip Stocks to Buy Now With Huge Piles of Cash and Very Low Debt

Court Rejects Patent Protection, Crushing Amarin Stock

Big Pharma Advances on COVID-19

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

Major Biotechs Get Mixed Message on Short Interest

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened